Richter transformation heralded by EBV reactivation during ibrutinib therapy for chronic lymphocytic leukemia

Leuk Lymphoma. 2021 Dec;62(12):3051-3053. doi: 10.1080/10428194.2021.1964023. Epub 2021 Aug 25.

Authors

Amandine Hansenne¹, Alessandra Camboni², Eric Van Den Neste¹, Sarah Bailly¹

Affiliations

¹ Service d'hématologie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
² Service d'anatomie Pathologique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

PMID: 34429010
DOI: 10.1080/10428194.2021.1964023

No abstract available

Publication types

Letter

MeSH terms

Adenine / analogs & derivatives
Herpesvirus 4, Human
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Lymphoma, Large B-Cell, Diffuse*
Piperidines

Substances

Piperidines
ibrutinib
Adenine